<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33118628</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4598</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Muscle &amp; nerve</Title><ISOAbbreviation>Muscle Nerve</ISOAbbreviation></Journal><ArticleTitle>Smartphone data during the COVID-19 pandemic can quantify behavioral changes in people with ALS.</ArticleTitle><Pagination><StartPage>258</StartPage><EndPage>262</EndPage><MedlinePgn>258-262</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mus.27110</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Passive data from smartphone sensors may be useful for health-care research. Our aim was to use the coronavirus disease-2019 (COVID-19) pandemic as a positive control to assess the ability to quantify behavioral changes in people with amyotrophic lateral sclerosis (ALS) from smartphone data.</AbstractText><AbstractText Label="METHODS">Eight participants used the Beiwe smartphone application, which passively measured their location during the COVID-19 outbreak. We used an interrupted time series to quantify the effect of the US state of emergency declaration on daily home time and daily distance traveled.</AbstractText><AbstractText Label="RESULTS">After the state of emergency declaration, median daily home time increased from 19.4 (interquartile range [IQR], 15.4-22.0) hours to 23.7 (IQR, 22.2-24.0) hours and median distance traveled decreased from 42 (IQR, 13-83) km to 3.7 (IQR, 1.5-10.3) km. The participant with the lowest functional ability changed behavior earlier. This participant stayed at home more and traveled less than the participant with highest functional ability, both before and after the state of emergency.</AbstractText><AbstractText Label="DISCUSSION">We provide evidence that smartphone-based digital phenotyping can quantify the behavior of people with ALS. Although participants spent large amounts of time at home at baseline, the COVID-19 state of emergency declaration reduced their mobility further. Given participants' high level of daily home time, it is possible that their exposure to COVID-19 could be less than that of the general population.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Muscle &amp; Nerve published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beukenhorst</LastName><ForeName>Anna L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-1765-4890</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Ella</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neurological Clinical Research Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burke</LastName><ForeName>Katherine M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Neurological Clinical Research Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Syed Minhajur</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Neurological Clinical Research Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clapp</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University, St. Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konanki</LastName><ForeName>Sai Charan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paganoni</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0505-1168</Identifier><AffiliationInfo><Affiliation>Neurological Clinical Research Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University, St. Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onnela</LastName><ForeName>Jukka-Pekka</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Neurological Clinical Research Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Philantrophic Support</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Muscle Nerve</MedlineTA><NlmUniqueID>7803146</NlmUniqueID><ISSNLinking>0148-639X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001519" MajorTopicYN="Y">Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040362" MajorTopicYN="Y">Geographic Information Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065186" MajorTopicYN="N">Interrupted Time Series Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063731" MajorTopicYN="Y">Mobile Applications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068997" MajorTopicYN="Y">Smartphone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014195" MajorTopicYN="Y">Travel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS, COVID-19, digital phenotyping, mobile health, smartphones</Keyword></KeywordList><CoiStatement>J.D.B. reports consulting fees from Biogen, Clene Nanomedicine, and Alexion. He has received research support from Biogen, MT Pharma of America, Anelixis Therapeutics, Amylyx Therapeutics, Brainstorm Cell Therapeutics, Genentech, nQ Medical, NINDS, Muscular Dystrophy Association, ALS One, and ALS Finding A Cure. S.P. reports research grants from the ALS Association, ALS Finding a Cure, the American Academy of Neurology, the Spastic Paraplegia Foundation, Amylyx Therapeutics, Revalesio Corp, Ra Pharma, Biohaven, Clene Nanomedicine, Prilenia. T.M.M. reports licensing agreements with C2N and Ionis Pharmaceuticals, has served on advisory boards for and receives material support from Biogen, and is a consultant for Cytokinetics and Disarm Therapeutics. J.&#x2010;P.O. receives his sole compensation as a faculty member of Harvard University. His research at the Harvard T.H. Chan School of Public Health is supported by research awards from the National Institutes of Health, Otsuka Pharmaceutical, Boehringer Ingelheim, and Apple. He received an unrestricted gift from Mindstrong Health in 2018. He is a cofounder and board member of a recently established commercial entity that operates in digital phenotyping. The remaining authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>29</Day><Hour>8</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33118628</ArticleId><ArticleId IdType="pmc">PMC7898508</ArticleId><ArticleId IdType="doi">10.1002/mus.27110</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
US Centers for Disease Control and Prevention
. Coronavirus disease 2019 (COVID&#x2010;19): social distancing, quarantine, and isolation. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/social-distancing.html. Last accessed 11/24/2020</Citation></Reference><Reference><Citation>
US Centers for Disease Control and Prevention
. Coronavirus disease 2019 (COVID&#x2010;19): People who are at higher risk for severe illness. https://www.cdc.gov/coronavirus/2019&#x2010;ncov/need&#x2010;extra&#x2010;precautions/people&#x2010;at&#x2010;higher&#x2010;risk.html. Last accessed 11/24/2020</Citation></Reference><Reference><Citation>Onnela JP, Rauch SL. Harnessing smartphone&#x2010;based digital phenotyping to enhance behavioral and mental health. Neuropsychopharmacology. 2016;41:1691&#x2010;1696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4869063</ArticleId><ArticleId IdType="pubmed">26818126</ArticleId></ArticleIdList></Reference><Reference><Citation>Onnela JP. Opportunities and challenges in the collection and analysis of digital phenotyping data. Neuropsychopharmacology. 2020. Jul 17. doi: 10.1038/s41386-020-0771-3. Epub ahead of print. PMID: 32679583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-020-0771-3</ArticleId><ArticleId IdType="pmc">PMC7688649</ArticleId><ArticleId IdType="pubmed">32679583</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry JD, Paganoni S, Carlson K, et al. Design and results of a smartphone&#x2010;based digital phenotyping study to quantify ALS progression. Ann Clin Transl Neurol. 2019;6:873&#x2010;881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6529832</ArticleId><ArticleId IdType="pubmed">31139685</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett I, Onnela JP. Inferring mobility measures from GPS traces with missing data. Biostatistics. 2020;21:e98&#x2010;e112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7868053</ArticleId><ArticleId IdType="pubmed">30371736</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46:348&#x2010;355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407170</ArticleId><ArticleId IdType="pubmed">27283160</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS&#x2010;R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Nguyen T, Rojas FL, et al. Tracking public and private responses to the COVID&#x2010;19 epidemic: evidence from state and local government actions. Nat Bureau Econ Res. 2020. 10.3386/w27027. 1&#x2010;38.</Citation><ArticleIdList><ArticleId IdType="doi">10.3386/w27027</ArticleId></ArticleIdList></Reference><Reference><Citation>Schl&#xfc;ter DK, Tennant A, Mills R, Diggle PJ, Young CA. Risk factors for social withdrawal in amyotrophic lateral sclerosis/motor neurone disease. Amyotroph Lat Scler Frontotemp Degen. 2018;19:591&#x2010;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">30398087</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>